Bingren Liu

Bingren Liu, B.Med. serves as Associate Professor of Clinical Radiation Oncology in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. He is an active faculty member of the University of Rochester Medical Faculty Group and Accountable Health Partners, providing clinical care at the Wilmot Cancer Institute in Rochester, NY. Dr. Liu specializes in treating all cancer types with particular expertise in prostate, breast, lung, and gynecologic malignancies, driven by his personal motivation from his sister's death from cancer.

His educational background includes:

• MD from Tianjin Medical University (China), 1990
• Residency in Internal Medicine at Long Island College Hospital (USA), 1999-2000
• Residency in Radiation Oncology at Ohio State University Wexner Medical Center, 2000-2004

Dr. Liu's research integrates radiation oncology with cancer biology, focusing on treatment techniques and molecular mechanisms. His work bridges clinical applications like image-guided brachytherapy with laboratory investigations into drug resistance pathways and viral oncology. This dual focus enables translational approaches connecting bench discoveries to bedside cancer therapies.

Analysis of his publication record (1994-2008) reveals an evolution from molecular studies of multidrug resistance in leukemia to clinical radiation therapy techniques for solid tumors. Early work examined MDR1 gene regulation and p53 interactions, while later research developed ultrasound-guided prostate brachytherapy protocols. Collectively, his articles demonstrate consistent emphasis on improving radiation treatment precision while investigating fundamental cancer biology.

Dr. Liu's scientific recognition includes:

• Shining Examples Award (2009)
• Young Scientist Award (1995)

As a clinician-educator, Dr. Liu contributes to medical student and resident training within the Radiation Oncology department, though specific advisory roles and grant funding details are not publicly documented. His clinical practice operates within the multidisciplinary framework of the Wilmot Cancer Institute, collaborating with surgical oncologists, medical oncologists, and supportive care specialists to deliver comprehensive cancer treatment.